This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Becton Dickinson Settles Dispute

Shares of Retractable Technologies (RVP - Get Report) rose nearly 50% on Friday, after Becton Dickinson (BDX - Get Report) announced that it will pay the company $100 million to settle years of litigation over claims that Becton used its market position to hinder competition.

Under the terms of the agreement, Retractable agreed to dismiss its suit against Becton in exchange for the payout. Becton said it will record an after-tax charge of $63 million, or 24 cents a share, in the third quarter.

In reaction, shares of Retractable rose $3.03 to $9.15, hitting a 52-week-high of $9.16 on more than 190,000 shares traded, well past the average daily volume of 16,989 shares. Becton shares rose 21 cents, or 0.4%, to $49.46.

"This agreement will enable us to focus all of our energies and resources on our most important task -- meeting significant health care needs through the production of safe, effective and competitively priced products," said Edward Ludwig, chairman, president and CEO of Becton, in a statement.

At the core of the suit was Retractable's VanishPoint safety syringe, which protects doctors and nurses from being accidentally stuck with a used needle. In January 2001, the company filed a lawsuit that claimed Becton, which had a competing product, effectively blocked its entrance into the market, because of its exclusive contracts with hospital suppliers.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BDX $140.51 0.00%
RVP $4.03 0.00%
AAPL $130.28 0.00%
FB $79.19 0.00%
GOOG $532.11 0.00%

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs